| Balance Sheets | 2025-07-31 | |||
|---|---|---|---|---|
| Cash | 19,084 | |||
| Research and development rebate due from australian government, net | 0 | |||
| Prepaid expenses and other current assets, net | 30,639 | |||
| Total current assets | 49,723 | |||
| Investment in oragenics, inc. common stock, at fair value | 0 | |||
| Total assets | 49,723 | |||
| Accounts payable and accrued wages | 1,615,357 | |||
| Accounts payable and accrued wages, officers | 1,858,443 | |||
| Accrued interest | 421,440 | |||
| Asset purchase liability | 1,125,026 | |||
| Notes payable, officers and directors | 100,000 | |||
| Notes payable, net of unamortized debt discounts and closing costs of 512 and 38,134 | 1,884,155 | |||
| Total current liabilities | 7,004,421 | |||
| Common stock, 0.001 par value, 500,000,000 shares authorized, 96,709,763 shares issued and outstanding | 96,710 | |||
| Additional paid-in-capital | 55,694,429 | |||
| Accumulated deficit | -62,745,837 | |||
| Total stockholders' deficit | -6,954,698 | |||
| Total liabilities and stockholders' deficit | 49,723 | |||
Odyssey Health, Inc. (ODYY)
Odyssey Health, Inc. (ODYY)